| abstract |
There is provided crystalline forms of N -[2-[[(2,3-difluorophenyl)methyl]thio]-6- {[(1 R ,2 S )-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfon-amide 5 anhydrate. Such compounds/forms may be useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. |